GSK

GSK Plc ADR

Oct 02 • 03:25PM ET

43.78

-1.72 -3.79 %

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: FVD AVDE PPH FENI RODM DFAX BINV AVIV PLDR FFLC

Index	-	P/E	20.40	EPS (ttm)	2.15	Insider Own	0.00%	Shs Outstand	2.02B	Perf Week	10.79%
Market Cap	88.12B	Forward P/E	8.99	EPS next Y	4.87	Insider Trans	-	Shs Float	2.01B	Perf Month	11.24%
Enterprise Value	106.34B	PEG	2.18	EPS next Q	1.27	Inst Own	19.09%	Short Float	0.55%	Perf Quarter	14.68%
Income	4.43B	P/S	2.15	EPS this Y	10.54%	Inst Trans	-1.36%	Short Ratio	2.30	Perf Half Y	16.33%
Sales	40.95B	P/B	4.37	EPS next Y	10.49%	ROA	5.73%	Short Interest	10.98M	Perf YTD	29.46%
Book/sh	10.02	P/C	17.77	EPS next 5Y	9.38%	ROE	23.04%	52W High	45.59 -3.96%	Perf Year	7.11%
Cash/sh	2.46	P/FCF	11.39	EPS past 3/5Y	-24.61% -11.63%	ROIC	10.74%	52W Low	31.72 38.06%	Perf 3Y	52.77%
Dividend Est.	1.75 (3.99%)	EV/EBITDA	8.91	Sales past 3/5Y	5.68% -1.42%	Gross Margin	71.69%	Volatility	2.63% 1.65%	Perf 5Y	13.78%
Dividend TTM	1.64 (3.75%)	EV/Sales	2.60	EPS Y/Y TTM	-13.29%	Oper. Margin	17.18%	ATR (14)	1.00	Perf 10Y	12.47%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	0.57	Sales Y/Y TTM	3.46%	Profit Margin	10.81%	RSI (14)	64.21	Recom	3.00
Dividend Gr. 3/5Y	-16.94% -9.13%	Current Ratio	0.87	EPS Q/Q	30.61%	SMA20	6.75%	Beta	0.50	Target Price	43.70
Payout	94.89%	Debt/Eq	1.17	Sales Q/Q	7.23%	SMA50	10.48%	Rel Volume	2.52	Prev Close	45.51
Employees	68629	LT Debt/Eq	1.03	Earnings	Jul 30 BMO	SMA200	15.82%	Avg Volume	4.78M	Price	43.78
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.58% 1.12%	Trades		Volume	11,007,943	Change	-3.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral

Show Previous Ratings

Today 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Oct-01-25 05:34PM	GSK (GSK) Touches All-Time High on Potential Exemption From Trump Tariff (Insider Monkey) +5.44%
04:36PM	Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff (Investor's Business Daily)
12:37PM	GSK's $30B US Gamble Sends Pharma Stocks Soaring After Trump Pricing Deal (GuruFocus.com)
10:00AM	New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level (Business Wire)
07:48PM	Loading…
Sep-30-25 07:48PM	Analyst Report: GSK plc (Morningstar Research) +5.01%
Sep-29-25 04:25PM	GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley (Investor's Business Daily)
11:18AM	GSK Will Replace CEO Walmsley With a Company Insider. The Stock Is Up. (Barrons.com)
10:11AM	GSK CEO Emma Walmsley to Step Down (The Wall Street Journal)
08:07AM	CoreWeave, AstraZeneca, GSK, BYD, Tesla: Trending Stocks (Yahoo Finance Video)
06:59AM	Stocks to Watch Monday: Carnival, GSK, Alibaba (The Wall Street Journal)
06:07AM	Premarket movers: Merus, GSK, Novo Nordisk (MarketWatch)
04:46AM	GSK turns to insider to be next CEO - and the stock rallies (MarketWatch)
02:47AM	GSK Chief Emma Walmsley to Step Down, Luke Miels Named Successor (The Wall Street Journal)
Sep-26-25 03:48PM	Analyst Report: GSK plc (Morningstar Research)
05:31AM	Loading…
05:31AM	Stock Market Today: Dow, S&P 500 and Nasdaq futures inch higher after three days of losses for stocks, with Fed's preferred inflation gauge ahead and fresh tariff announcements from Trump (MarketWatch)
05:30AM	U.S. stock futures indicate a losing streak could be over as PCE inflation looms and after fresh tariffs announced (MarketWatch)
Sep-24-25 10:16AM	Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock? (Zacks)
Sep-23-25 02:15PM	IONS' Rare Neurological Disease Drug Meets Late-Stage Study Goal (Zacks)
09:50AM	Why GSK (GSK) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-22-25 06:40PM	GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism (CNBC TV)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Sep-18-25 11:38AM	RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline (Zacks)
02:10AM	GSK Commits $30 Billion To U.S. Expansion Over Five Years (GuruFocus.com)
Sep-17-25 03:52PM	GSK Commits $30B to Boost U.S. Pharma Expansion (GuruFocus.com)
03:23PM	GSK Just Dropped $30 Billion on America's Biotech Future--Here's What That Buys (GuruFocus.com)
11:56AM	GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years (Zacks)
11:22AM	LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off? (Zacks)
10:46AM	Trump's UK visit: US Big Tech to invest billions in UK's AI (Yahoo Finance Video)
07:30AM	Drugmakers' Pledges to Boost U.S. Manufacturing Pile Up (The Wall Street Journal)
05:35AM	Loading…
05:35AM	Stocks to Watch Wednesday: Workday, StubHub, General Mills (The Wall Street Journal)
Sep-16-25 08:00PM	Drugmakers Have Pledged to Invest $350 Billion in U.S. After Tariff Threat (The Wall Street Journal)
07:01PM	GSK Says It Will Spend $30B on U.S. Manufacturing and R&D (Barrons.com)
11:15AM	Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Sep-11-25 12:49PM	Kepler Capital Maintains a Hold Rating on GSK plc (GSK) (Insider Monkey)
11:30AM	Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report? (Zacks)
Sep-06-25 12:58AM	TD Cowen Maintains a Hold Rating on GSK plc (GSK), Sets a PT of $45 (Insider Monkey)
Sep-03-25 11:30AM	BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound? (Zacks)
10:47AM	IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride (Zacks)
Sep-02-25 05:33PM	Top Analyst Reports for NVIDIA, Chevron & Booking (Zacks)
09:48AM	GSK Adds Around $5B in a Month: Here's How to Play the Stock (Zacks)
Aug-26-25 09:40AM	GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU (Zacks)
Aug-22-25 11:11AM	BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now? (Zacks)
Aug-21-25 09:49AM	JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug (Zacks)
Aug-18-25 09:25AM	GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait? (Zacks)
Aug-13-25 12:31PM	Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y (Zacks)
Aug-11-25 04:19AM	GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic (Investing.com)
Aug-08-25 09:23AM	GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up (Zacks)
03:31AM	GSK to Receive $370 Million in U.S. Patent Litigation Settlement (The Wall Street Journal)
Aug-04-25 07:58AM	GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Aug-01-25 07:46AM	Stocks Buckle Under Trump Tariffs; Amazon Slumps: Markets Wrap (Bloomberg)
07:21AM	Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices (The Wall Street Journal)
05:57AM	Stock Market Today: Stocks Fall on Trump's Tariff Blitz; Jobs Report Due (The Wall Street Journal)
Jul-31-25 04:16PM	What Trump's Big Pharma CEO letters mean for drug pricing power (Yahoo Finance Video)
09:22AM	Company News for Jul 31, 2025 (Zacks)
Jul-30-25 05:48PM	Analyst Report: GSK plc (Morningstar Research)
11:57AM	GSK CEO: Innovation is the secret to bringing down cost of overall healthcare (CNBC TV)
11:42AM	GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise (Zacks)
09:21AM	GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth (Benzinga)
07:05AM	GSK (GSK) Q2 Earnings and Revenues Beat Estimates (Zacks)
02:49AM	GSK Upbeat on Guidance After Specialty Medicines Boost Sales (The Wall Street Journal)
Jul-27-25 09:53PM	Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology (PR Newswire)
Jul-24-25 02:59PM	Europes Pharma Stocks Look Cheap but Tariffs Cloud the Outlook (Barrons.com)
10:00AM	Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:00AM	GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults (Business Wire)
Jul-23-25 10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-21-25 09:38AM	Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect (Zacks)
Jul-19-25 11:12AM	Warren Buffett says this book changed his life forever. Here's the real key to long-term gains (Moneywise)
Jul-18-25 09:32PM	Stock Market News, July 18, 2025: Another Record for Nasdaq (The Wall Street Journal)
02:47PM	BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510 (Insider Monkey)
01:23PM	Global Stocks Recap: Alibaba, Saab, Burberry, GSK (The Wall Street Journal)
10:39AM	FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo (Zacks)
09:30AM	Global Stocks in the Spotlight: Alibaba, Saab, Burberry, GSK (The Wall Street Journal)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:39AM	Stocks to Watch Friday: Chevron, Hess, Netflix, 3M (The Wall Street Journal)
07:32AM	GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning (Benzinga)
Jul-17-25 06:19PM	FDA Committee Votes Against GSK Blood Cancer Drug Blenrep (The Wall Street Journal)
02:37PM	GSK stock falls after FDA panel rejects blood cancer drug Blenrep (Investing.com)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
07:00AM	US FDA Approves GSKs SHINGRIX in a Prefilled Syringe Presentation (Business Wire)
Jul-15-25 12:54PM	Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention (Zacks)
Jul-14-25 10:12AM	FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults (Zacks)
Jul-12-25 09:36AM	FDA willing to trade faster drug reviews for lower prices, Bloomberg reports (TipRanks)
Jul-10-25 09:13AM	GSK begins shipping influenza vaccine doses for the 2025-26 flu season (Business Wire)
Jul-09-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:19AM	GSK's Specialty Medicines Unit on a Strong Footing: Here's Why (Zacks)
Jul-08-25 09:51AM	Gilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock? (Zacks)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Jul-04-25 09:00AM	How Much of Your Portfolio Should Be in International Stocks? (The Wall Street Journal)
Jul-03-25 12:10PM	Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:36AM	Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna. (Investor's Business Daily)
09:06AM	MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations (Zacks)
Jul-02-25 04:33PM	Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up. (Barrons.com)
09:10AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jul-01-25 09:33AM	Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock? (Zacks)
09:17AM	Moderna Stock Gains on Encouraging Flu Vaccine Data (Zacks)
Jun-27-25 04:25PM	Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care (Investor's Business Daily)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK

GSK Plc ADR

Upgrade your FINVIZ experience